title: LIF and CNTF, which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats.
abstract: We determined the effects of leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) on lipid metabolism in intact rats. Administration of LIF and CNTF increased serum triglycerides in a dose-dependent manner with peak values at 2 h. The effects of LIF and CNTF on serum cholesterol were very small, and serum glucose was unaffected. Both LIF and CNTF stimulated hepatic triglyceride secretion, hepatic de novo fatty acid synthesis, and lipolysis. Pretreatment with phenylisopropyl adenosine, which inhibits lipolysis, partially inhibited LIF- and CNTF-induced hypertriglyceridemia. Interleukin-4, which inhibits cytokine-induced hepatic fatty acid synthesis, also partially inhibited LIF- and CNTF-induced hypertriglyceridemia. These results indicate that both lipolysis and de novo fatty acid synthesis play a role in providing fatty acids for the increase in hepatic triglyceride secretion. Neither indomethacin nor adrenergic receptor antagonists affected the hypertriglyceridemia. The combination of LIF plus CNTF showed no additive effects consistent with the action of both cytokines through the gp130 transduction system. Thus LIF and CNTF have similar effects on lipid metabolism; they join a growing list of cytokines that stimulate hepatic triglyceride secretion and may mediate the changes in lipid metabolism that accompany the acute phase response.
authors.affiliation: Department of Medicine, University of California, San Francisco 94143, USA.
authors.forename: K
authors.initials: K
authors.lastname: Nonogaki
authors.forename: X M
authors.initials: XM
authors.lastname: Pan
authors.forename: A H
authors.initials: AH
authors.lastname: Moser
authors.forename: J
authors.initials: J
authors.lastname: Shigenaga
authors.forename: I
authors.initials: I
authors.lastname: Staprans
authors.forename: N
authors.initials: N
authors.lastname: Sakamoto
authors.forename: C
authors.initials: C
authors.lastname: Grunfeld
authors.forename: K R
authors.initials: KR
authors.lastname: Feingold
mesh_terms: D000818:Animals; D020934:Ciliary Neurotrophic Factor; D006131:Growth Inhibitors / Q000494:pharmacology*; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008222:Lymphokines / Q000494:pharmacology*; D051907:Lysosomal Membrane Proteins; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects*; D052118:Lysosomal-Associated Membrane Protein 1
chemical_list: D020934:Ciliary Neurotrophic Factor; D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D051907:Lysosomal Membrane Proteins; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; C489117:Lamp1 protein, rat; D052118:Lysosomal-Associated Membrane Protein 1